Provided By PR Newswire
Last update: Jan 31, 2025
NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquisition of the company by Zimmer Biomet Holdings, Inc. (NYSE: ZBH). Stockholders will receive $13.00 and a contingent value right for up to $1.00 for each share of Paragon 28 stock that they hold. The transaction is valued at approximately $1.2 billion and is expected to close in the first half of 2025.
Read more at prnewswire.comNYSE:ZBH (6/6/2025, 11:17:08 AM)
92.535
+0.61 (+0.67%)
Find more stocks in the Stock Screener
ZIMMER BIOMET HOLDINGS (NYSE:ZBH) is an undervalued medical device stock with strong profitability, reasonable debt, and improving growth prospects, making it a candidate for value investors.
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and decent financial health, making it a candidate for income investors.
Stay updated with the S&P500 gap up and gap down stocks on Monday. Get a glimpse of the market's movement during today's session.